Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/31/25 16:19 | 3/27/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Bergstrom Donald A | MA | O | P,R,D | 2 | S.m | -365 | 4.48 | 0 | -81 | 616 | D | |||||||||||||||
3/31/25 16:15 | 3/27/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Rahmer Peter | MA | O | See rema | 2 | S.m | -205 | 4.49 | 0 | -46 | 402 | D | |||||||||||||||
3/31/25 16:13 | 3/27/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Catinazzo Thomas | MA | O | CFO | 2 | S.m | -282 | 4.42 | 0 | -64 | 379 | D | |||||||||||||||
3/31/25 16:12 | 3/27/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Adams Brian | MA | O | GC | 2 | S.m | -249 | 4.54 | 0 | -55 | 406 | D | |||||||||||||||
2/13/25 20:56 | 2/11/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Patel Sanjiv | MA | DO | P,CEO | 2 | S.m | -2,581 | 4.37 | 0 | -591 | 1,770 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |